ABOUT US
VitaK bv Management
Dr. Vermeer studied Biochemistry at Leiden, where he also presented
his PhD thesis (1974) on the initiation of protein biosynthesis
in E coli. In 1975 Dr. Vermeer was appointed at the Department of
Biochemistry of the Universiteit Maastricht, where he has founded
the Division on Vitamin K In 1984 he was appointed as an Associate
Professor of Biochemistry and Principal Investigator at CARIM. In
1994 Dr. Vermeer was appointed as a temporary advisor of the World
Health Organization and in 2001 he received the honorary title of
Doctor honoris causa at the University of Medicine and Pharmacy
"Iuliu Hatieganu" of the city of Cluj-Napoca, Romania.
Moreover, in 2001 Dr. Vermeer founded the company VitaK BV, where
he became the first CEO of the company. Profile Dr. Schurgers: Dr.
Schurgers defended his PhD thesis (2002) at CARIM on the role of
vitamins K1 and K2 in bone metabolism and cardiovascular disease.
He received a post-doc position at VitaK in 2001 and was appointed
as Vice President and Scientific Director in 2004. In 2007 he also
became an honorary senior scientist at CARIM. He is a member of
the 'American Heart Association', the 'American Society of Bone
and Mineral Research', and the ‘International Society of Thrombosis
and Haemostasis’. Finally, Dr. Schurgers is also a board member
of KEQAS, the world wide vitamin K external quality assurance scheme. Dr. Schurgers did his PhD thesis (2002) at the cardiovascular research institute, University Maastricht on the role of vitamin K1 and K2 in bone metabolism and cardiovascular disease. Dr. Schurgers is working for the Division on Vitamin K Research. This Division forms an essential part of the Cardiovascular Research Institute CARIM, which is the largest research institute of the University of Maastricht. The work includes molecular biology, biochemistry, animal and human nutrition, pharmacology, and clinical studies in the fields of atherosclerosis and osteoporosis. He is a member of the 'American Heart Association', the 'American Society of Bone and Mineral Research', and the ‘International Society of Thrombosis and Haemostasis’. In 2001 Dr. Schurgers was appointed as Vice President of VitaK. |
